Gene Mack serves as Executive at Gain Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gene Mack has executed 1 insider transactions totaling $14.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2024 involved purchasing 14,400 shares valued at $14.5K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Aug 9, 2024 | GANX | $14.5K | Purchase | 14,400 | $1.01 | Discretionary |
Gene Mack currently holds 14,400 shares of Gain Therapeutics, Inc. (GANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gene Mack has been a net buyer of GANX stock. They have purchased $14.5K and sold $0 worth of shares.
Gene Mack's most recent insider trade was on Aug 9, 2024, when they purchased 14,400 shares at $1.01 per share.
Get notified when new Form 4 filings are submitted